SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bellicum Pharmaceuticals, Inc. Release: Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine in Phase I/II Study